Table of Contents Chapter 1 Overview of Morphine 1.1 Definition of Morphine in This Report 1.2 Commercial Types of Morphine 1.2.1 Oral Tablets 1.2.2 Injection 1.2.3 Capsule 1.2.4 Others 1.3 Downstream Application of Morphine 1.3.1 Anesthesia 1.3.2 Cough Suppressant 1.3.3 Diarrhea suppressant 1.4 Development History of Morphine 1.5 Market Status and Trend of Morphine 2013-2023 1.5.1 Global Morphine Market Status and Trend 2013-2023 1.5.2 Regional Morphine Market Status and Trend 2013-2023 Chapter 2 Global Market Status and Forecast by Regions 2.1 Market Development of Morphine 2013-2017 2.2 Production Market of Morphine by Regions 2.2.1 Production Volume of Morphine by Regions 2.2.2 Production Value of Morphine by Regions 2.3 Demand Market of Morphine by Regions 2.4 Production and Demand Status of Morphine by Regions 2.4.1 Production and Demand Status of Morphine by Regions 2013-2017 2.4.2 Import and Export Status of Morphine by Regions 2013-2017 Chapter 3 Global Market Status and Forecast by Types 3.1 Production Volume of Morphine by Types 3.2 Production Value of Morphine by Types 3.3 Market Forecast of Morphine by Types Chapter 4 Global Market Status and Forecast by Downstream Industry 4.1 Demand Volume of Morphine by Downstream Industry 4.2 Market Forecast of Morphine by Downstream Industry Chapter 5 Market Driving Factor Analysis of Morphine 5.1 Global Economy Situation and Trend Overview 5.2 Morphine Downstream Industry Situation and Trend Overview Chapter 6 Morphine Market Competition Status by Major Manufacturers 6.1 Production Volume of Morphine by Major Manufacturers 6.2 Production Value of Morphine by Major Manufacturers 6.3 Basic Information of Morphine by Major Manufacturers 6.3.1 Headquarters Location and Established Time of Morphine Major Manufacturer 6.3.2 Employees and Revenue Level of Morphine Major Manufacturer 6.4 Market Competition News and Trend 6.4.1 Merger, Consolidation or Acquisition News 6.4.2 Investment or Disinvestment News 6.4.3 New Product Development and Launch Chapter 7 Morphine Major Manufacturers Introduction and Market Data 7.1 Mallinckrodt Pharmaceuticals 7.1.1 Company profile 7.1.2 Representative Morphine Product 7.1.3 Morphine Sales, Revenue, Price and Gross Margin of Mallinckrodt Pharmaceuticals 7.2 Alcaliber 7.2.1 Company profile 7.2.2 Representative Morphine Product 7.2.3 Morphine Sales, Revenue, Price and Gross Margin of Alcaliber 7.3 Purdue Pharma 7.3.1 Company profile 7.3.2 Representative Morphine Product 7.3.3 Morphine Sales, Revenue, Price and Gross Margin of Purdue Pharma 7.4 Cepia-Sanofi 7.4.1 Company profile 7.4.2 Representative Morphine Product 7.4.3 Morphine Sales, Revenue, Price and Gross Margin of Cepia-Sanofi 7.5 Macfarlan Smith 7.5.1 Company profile 7.5.2 Representative Morphine Product 7.5.3 Morphine Sales, Revenue, Price and Gross Margin of Macfarlan Smith 7.6 SUN PHARMA 7.6.1 Company profile 7.6.2 Representative Morphine Product 7.6.3 Morphine Sales, Revenue, Price and Gross Margin of SUN PHARMA 7.7 Qinghai Pharmaceutical 7.7.1 Company profile 7.7.2 Representative Morphine Product 7.7.3 Morphine Sales, Revenue, Price and Gross Margin of Qinghai Pharmaceutical 7.8 Taj Pharmaceuticals 7.8.1 Company profile 7.8.2 Representative Morphine Product 7.8.3 Morphine Sales, Revenue, Price and Gross Margin of Taj Pharmaceuticals 7.9 Northeast Pharm 7.9.1 Company profile 7.9.2 Representative Morphine Product 7.9.3 Morphine Sales, Revenue, Price and Gross Margin of Northeast Pharm Chapter 8 Upstream and Downstream Market Analysis of Morphine 8.1 Industry Chain of Morphine 8.2 Upstream Market and Representative Companies Analysis 8.3 Downstream Market and Representative Companies Analysis Chapter 9 Cost and Gross Margin Analysis of Morphine 9.1 Cost Structure Analysis of Morphine 9.2 Raw Materials Cost Analysis of Morphine 9.3 Labor Cost Analysis of Morphine 9.4 Manufacturing Expenses Analysis of Morphine Chapter 10 Marketing Status Analysis of Morphine 10.1 Marketing Channel 10.1.1 Direct Marketing 10.1.2 Indirect Marketing 10.1.3 Marketing Channel Development Trend 10.2 Market Positioning 10.2.1 Pricing Strategy 10.2.2 Brand Strategy 10.2.3 Target Client 10.3 Distributors/Traders List Chapter 11 Report Conclusion Chapter 12 Research Methodology and Reference 12.1 Methodology/Research Approach 12.1.1 Research Programs/Design 12.1.2 Market Size Estimation 12.1.3 Market Breakdown and Data Triangulation 12.2 Data Source 12.2.1 Secondary Sources 12.2.2 Primary Sources 12.3 Reference

List of Tables Table Advantage and Disadvantage of Oral Tablets Table Advantage and Disadvantage of Injection Table Advantage and Disadvantage of Capsule Table Advantage and Disadvantage of Others Table Production Volume of Morphine by Regions 2013-2017 Table Production Value of Morphine by Regions 2013-2017 Table Demand Volume of Morphine by Regions 2013-2017 Table Production and Demand Status of Morphine in Region One 2013-2017 Table Production and Demand Status of Morphine in Region Two 2013-2017 Table Production and Demand Status of Morphine in Region Three 2013-2017 Table Production and Demand Status of Morphine in Region Four 2013-2017 Table Import Volume of Morphine by Regions 2013-2017 Table Export Volume of Morphine by Regions 2013-2017 Table Production Volume of Morphine by Types 2013-2017 Table Production Value of Morphine by Types 2013-2017 Table Production Volume Forecast of Morphine by Types 2018-2023 Table Production Value Forecast of Morphine by Types 2018-2023 Table Demand Volume of Morphine by Downstream Industry 2013-2017 Table Demand Volume Forecast of Morphine by Downstream Industry 2018-2023 Table Production Volume of Morphine by Major Manufacturers 2013-2017 Table Production Value of Morphine by Major Manufacturers 2013-2017 Table Headquarters Location and Established Time of Morphine Major Manufacturer Table Employees and Revenue Level of Morphine Major Manufacturer Table Representative Morphine Product One of Mallinckrodt Pharmaceuticals Table Representative Morphine Product Two of Mallinckrodt Pharmaceuticals Table Morphine Sales, Revenue, Price and Gross Margin of Mallinckrodt Pharmaceuticals 2013-2017 Table Representative Morphine Product One of Alcaliber Table Representative Morphine Product Two of Alcaliber Table Morphine Sales, Revenue, Price and Gross Margin of Alcaliber 2013-2017 Table Representative Morphine Product One of Purdue Pharma Table Representative Morphine Product Two of Purdue Pharma Table Morphine Sales, Revenue, Price and Gross Margin of Purdue Pharma 2013-2017 Table Representative Morphine Product One of Cepia-Sanofi Table Representative Morphine Product Two of Cepia-Sanofi Table Morphine Sales, Revenue, Price and Gross Margin of Cepia-Sanofi 2013-2017 Table Representative Morphine Product One of Macfarlan Smith Table Representative Morphine Product Two of Macfarlan Smith Table Morphine Sales, Revenue, Price and Gross Margin of Macfarlan Smith 2013-2017 Table Representative Morphine Product One of SUN PHARMA Table Representative Morphine Product Two of SUN PHARMA Table Morphine Sales, Revenue, Price and Gross Margin of SUN PHARMA 2013-2017 Table Representative Morphine Product One of Qinghai Pharmaceutical Table Representative Morphine Product Two of Qinghai Pharmaceutical Table Morphine Sales, Revenue, Price and Gross Margin of Qinghai Pharmaceutical 2013-2017 Table Representative Morphine Product One of Taj Pharmaceuticals Table Representative Morphine Product Two of Taj Pharmaceuticals Table Morphine Sales, Revenue, Price and Gross Margin of Taj Pharmaceuticals 2013-2017 Table Representative Morphine Product One of Northeast Pharm Table Representative Morphine Product Two of Northeast Pharm Table Morphine Sales, Revenue, Price and Gross Margin of Northeast Pharm 2013-2017